EUVIMEDEUVIMED entdecken
Crossref

Sitagliptin in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Public Health and Health Equity Perspective

M. Olowofeso Abisola, E. Miller Franki, S. Zinkevich Natalya

Cardiovascular Science · 2025

DOI: 10.70322/cvs.2025.10010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Science, 2025. Verfasst von M. Olowofeso Abisola und 2 weiteren Autor:innen. Die Arbeit nennt 83 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Abisola, M. O., Franki, E. M., & Natalya, S. Z. (2025). Sitagliptin in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Public Health and Health Equity Perspective. Cardiovascular Science. https://doi.org/10.70322/cvs.2025.10010

Vancouver

Abisola MO, Franki EM, Natalya SZ. Sitagliptin in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Public Health and Health Equity Perspective. Cardiovascular Science. 2025. doi:10.70322/cvs.2025.10010

BibTeX
@article{Abisola2025,
  author = {Abisola, M. Olowofeso and Franki, E. Miller and Natalya, S. Zinkevich},
  title = {Sitagliptin in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Public Health and Health Equity Perspective},
  journal = {Cardiovascular Science},
  year = {2025},
  doi = {10.70322/cvs.2025.10010}
}
Kostenlos starten →